Join global biopharma leaders, investors, and innovators for a full-day forum focused on navigating today’s complex market landscape. Co-hosted by MSQ Ventures, The BayHelix Group, American Healthcare Executive Association, and Harvard Chinese Students and Scholars Association. Supported by IntelliPro and BioCentury Inc. this exclusive event offers high-impact sessions, strategic networking, and company presentations.
Speakers will include executives from global pharmaceutical companies, cutting-edge biotech firms, and venture firms.
MEET THE SPEAKERS
Josh Brelin
Head of Corporate Alliances & BD
BioCentury
Nikhil Mutyal
Head of Search and Evaluation
AstraZeneca
Alex Cogdill
Head of Strategic Initiatives, Global BD
Daiichi Sankyo US
Jens Bitsch-Norhave
Corp VP, Global Head of Corp Dev, BD, AM & Strategy
Hengrui Pharma
Weiyong Sun
Chief Business Officer
Hansoh Pharma
Echo Hindle-Yang
Founder & CEO
MSQ Ventures
Panel Moderator
Chong Xu
Partner
F-Prime Capital
Lou Kassa
Founder and Advisor
Hatch Biofund
Jan Shen
Founder & CEO
NeuShen Therapeutics
Pengpeng Li
Vice President
Lilly Asia Venture
Naveen Krishnan
SVP & Managing Director
Mirae Asset Capital Life Science
Linda Zhao
Managing Director
MSQ Ventures
Panel Moderator
Alan Jiang
Chief Strategy Officer
XtalPi
Rui (Sammi) Tang
SVP, Global Head of Quantitative Sciences & Evidence Generation
Astellas Pharma
Zhiyong (Sean) Xie
VP, Head of AI & Data Science
Xellar Biosystems
Ming “Tommy” Tang
Director of Bioinformatics
AstraZeneca
Gary Ma
Partner & SVP
Taimei Technology
Panel Moderator
SHANSHAN XU
CEO & Founder
Bambusa Therapeutics
JIMMY ZHANG
Executive Mentor, QB3 Bakar Labs / SVP BD
Frontier Biotech
ALVIN LUK
CEO & Founder
HuidaGene
WU CHENBING
CEO
EpimAb Biotherapeutics
Yao Zhang
Executive Director, Oncology Tech Strategy
GSK
Wendy Pan
Partner
Goodwin
Panel Moderator
If you are building, funding, or expanding a global biopharma business, this is a must-attend event for insights and networking.